Clean Science & Technology Ltd
Incorporated in 2003, Clean Science and Technology Ltd is one of the leading chemical manufacturers globally. It manufactures functionally critical specialty chemicals such as Performance Chemicals (MEHQ, BHA, and AP), Pharmaceutical Intermediates (Guaiacol and DCC), and FMCG Chemicals (4-MAP and Anisole). [1]
- Market Cap ₹ 8,740 Cr.
- Current Price ₹ 822
- High / Low ₹ 1,600 / 770
- Stock P/E 32.2
- Book Value ₹ 146
- Dividend Yield 0.73 %
- ROCE 29.3 %
- ROE 21.9 %
- Face Value ₹ 1.00
Pros
- Company is almost debt free.
- Company has a good return on equity (ROE) track record: 3 Years ROE 25.1%
- Company has been maintaining a healthy dividend payout of 20.3%
Cons
- Promoter holding has decreased over last 3 years: -27.5%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals
Part of BSE 500 Nifty 500 BSE Allcap BSE Commodities BSE 250 SmallCap Index
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 164 | 140 | 191 | 241 | 393 | 419 | 512 | 685 | 936 | 789 | 922 | 864 | |
| 106 | 92 | 118 | 168 | 256 | 234 | 253 | 385 | 533 | 452 | 523 | 495 | |
| Operating Profit | 58 | 48 | 72 | 73 | 137 | 186 | 260 | 300 | 403 | 338 | 400 | 369 |
| OPM % | 35% | 34% | 38% | 30% | 35% | 44% | 51% | 44% | 43% | 43% | 43% | 43% |
| 3 | 2 | 4 | 5 | 11 | 11 | 25 | 30 | 39 | 38 | 36 | 39 | |
| Interest | 3 | 3 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 |
| Depreciation | 5 | 6 | 6 | 8 | 11 | 14 | 17 | 25 | 36 | 44 | 44 | 44 |
| Profit before tax | 53 | 41 | 70 | 70 | 137 | 182 | 267 | 305 | 405 | 331 | 391 | 363 |
| Tax % | 34% | 34% | 33% | 30% | 28% | 23% | 26% | 25% | 25% | 25% | 25% | |
| 35 | 27 | 47 | 49 | 98 | 140 | 198 | 229 | 304 | 248 | 292 | 272 | |
| EPS in Rs | 247.58 | 192.41 | 330.79 | 343.72 | 690.82 | 1,051.82 | 18.68 | 21.52 | 28.57 | 23.31 | 27.51 | 25.57 |
| Dividend Payout % | 10% | 13% | 12% | 12% | 15% | 2% | 134% | 15% | 18% | 21% | 22% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 19% |
| 5 Years: | 17% |
| 3 Years: | 10% |
| TTM: | -4% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 24% |
| 5 Years: | 16% |
| 3 Years: | 9% |
| TTM: | -6% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -18% |
| 1 Year: | -45% |
| Return on Equity | |
|---|---|
| 10 Years: | 30% |
| 5 Years: | 29% |
| 3 Years: | 25% |
| Last Year: | 22% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 1 | 1 | 1 | 1 | 1 | 1 | 11 | 11 | 11 | 11 | 11 | 11 |
| Reserves | 76 | 99 | 143 | 186 | 271 | 341 | 529 | 758 | 1,008 | 1,205 | 1,446 | 1,545 |
| 20 | 12 | 0 | 1 | 3 | 3 | 0 | 0 | 1 | 1 | 1 | 1 | |
| 29 | 27 | 35 | 48 | 53 | 85 | 120 | 156 | 139 | 154 | 147 | 156 | |
| Total Liabilities | 127 | 139 | 179 | 236 | 328 | 430 | 660 | 925 | 1,159 | 1,371 | 1,605 | 1,713 |
| 60 | 64 | 77 | 101 | 126 | 166 | 186 | 296 | 427 | 401 | 364 | 351 | |
| CWIP | 0 | 0 | 2 | 1 | 4 | 3 | 55 | 44 | 4 | 2 | 4 | 5 |
| Investments | 1 | 1 | 32 | 18 | 76 | 134 | 233 | 247 | 428 | 666 | 907 | 1,076 |
| 65 | 75 | 68 | 115 | 122 | 127 | 187 | 338 | 300 | 302 | 330 | 281 | |
| Total Assets | 127 | 139 | 179 | 236 | 328 | 430 | 660 | 925 | 1,159 | 1,371 | 1,605 | 1,713 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 69 | 45 | 85 | 160 | 193 | 127 | 299 | 277 | 279 | |||
| -52 | -17 | -94 | -106 | -186 | -124 | -245 | -228 | -221 | |||
| -15 | -5 | -11 | -55 | -6 | -0 | -55 | -53 | -52 | |||
| Net Cash Flow | 2 | 23 | -20 | -1 | 1 | 4 | -0 | -3 | 6 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 36 | 68 | 41 | 60 | 55 | 61 | 53 | 82 | 58 | 75 | 73 |
| Inventory Days | 202 | 246 | 165 | 93 | 79 | 98 | 156 | 143 | 122 | 146 | 118 |
| Days Payable | 71 | 79 | 73 | 85 | 48 | 101 | 180 | 166 | 90 | 121 | 83 |
| Cash Conversion Cycle | 166 | 235 | 134 | 69 | 87 | 58 | 29 | 59 | 89 | 100 | 108 |
| Working Capital Days | 87 | 131 | 64 | 61 | 62 | 33 | 32 | 90 | 66 | 78 | 79 |
| ROCE % | 42% | 55% | 42% | 59% | 59% | 61% | 47% | 45% | 29% | 29% |
Documents
Announcements
- Announcement under Regulation 30 (LODR)-Newspaper Publication 1d
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
31 Jan - Audio recording of Q3 FY26 earnings call uploaded on 31 January 2026.
-
Announcement under Regulation 30 (LODR)-Dividend Updates
31 Jan - Declared Rs.2.00 interim dividend; approved Q3 and nine-month results; record date Feb 6, payment Feb 25, 2026.
-
Interim Dividend Shall Be Paid To The Equity Shareholders Whose Name Appears In The Register Of Member Of The Company As On Friday, 6Th February, 2026 Being Record Date Fixed For The Purpose.
31 Jan - Approved unaudited results to 31 Dec 2025; interim dividend Rs21/share; record date 6 Feb 2026.
- Corporate Action-Board approves Dividend 31 Jan
Annual reports
Concalls
-
Jan 2026TranscriptAI SummaryPPT
-
Nov 2025Transcript PPT REC
-
Jul 2025Transcript PPT REC
-
May 2025Transcript PPT REC
-
Feb 2025Transcript PPT REC
-
Nov 2024Transcript PPT REC
-
Aug 2024Transcript PPT
-
May 2024Transcript PPT REC
-
Feb 2024Transcript PPT REC
-
Jan 2024TranscriptAI SummaryPPTREC
-
Nov 2023Transcript PPT REC
-
Aug 2023Transcript PPT REC
-
May 2023Transcript PPT REC
-
Feb 2023Transcript PPT REC
-
Oct 2022Transcript PPT
-
Aug 2022Transcript PPT
-
Jun 2022Transcript PPT
-
Feb 2022Transcript PPT
-
Nov 2021Transcript PPT
-
Aug 2021Transcript PPT
Product Segment [1]
1) Performance Chemicals (69% in FY25 vs 69% in FY22): It manufactures Monomethyl Ether of Hydroquinone (MEHQ), used as a polymerization inhibitor in acrylic acids, acrylic esters, super absorbent polymers (diapers and sanitary pads), Butylated Hydroxy Anisole (BHA), used as anti-oxidant in food and feed industry, Ascorbyl Palmitate (AP), used in infant food formulations, breakfast cereals, and cosmetics, Tertiary Butyl Hydroquinone (TBHQ) used as a stabilizer in the oil industry and Hindered Amine light Stabilizers (HALS), used in water treatment and UV stabilization in a variety of polymers. TBHQ ranks 2nd globally, while the rest of the products are ranked no.1.